Nick H Ten Hacken
Overview
Explore the profile of Nick H Ten Hacken including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
14
Citations
658
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Turan N, van der Veen T, Draijer C, Fattahi F, Ten Hacken N, Timens W, et al.
Front Allergy
. 2022 Apr;
2:676930.
PMID: 35387061
Asthma is a heterogenous disease with different inflammatory subgroups that differ in disease severity. This disease variation is hampering treatment and development of new treatment strategies. Macrophages may contribute to...
2.
de Weger W, Klooster K, Ten Hacken N, van Dijk M, Hartman J, Slebos D
Lung
. 2020 Jun;
198(4):629-636.
PMID: 32596757
Background: Bronchoscopic lung volume reduction techniques are minor invasive treatment modalities for severely hyperinflated emphysema patients. The severity of static lung hyperinflation determines eligibility and success rate for these treatments....
3.
Slebos D, Ten Hacken N, Hetzel M, Herth F, Shah P
Respiration
. 2018 Jul;
96(1):1-11.
PMID: 29991060
Endobronchial coils are an additional treatment option for lung volume reduction in patients with severe emphysema. Patient selection should be focused on patients with severe emphysema on optimal medical therapy...
4.
Kruk D, Heijink I, Slebos D, Timens W, Ten Hacken N
Respiration
. 2018 May;
96(2):148-158.
PMID: 29719298
Mesenchymal stem or stromal cells (MSCs) are multipotent cells that play a pivotal role in various phases of lung development and lung homeostasis, and potentially also lung regeneration. MSCs do...
5.
Kemp S, Slebos D, Kirk A, Kornaszewska M, Carron K, Ek L, et al.
Am J Respir Crit Care Med
. 2017 Sep;
196(12):1535-1543.
PMID: 28885054
Rationale: Single-center randomized controlled trials of the Zephyr endobronchial valve (EBV) treatment have demonstrated benefit in severe heterogeneous emphysema. This is the first multicenter study evaluating this treatment approach. Objectives:...
6.
Kunz L, Ten Hacken N, Lapperre T, Timens W, Kerstjens H, van Schadewijk A, et al.
Eur Respir J
. 2017 Jun;
49(6).
PMID: 28619964
No abstract available.
7.
Draijer C, Boorsma C, Robbe P, Timens W, Hylkema M, Ten Hacken N, et al.
J Allergy Clin Immunol
. 2016 Dec;
140(1):280-283.e3.
PMID: 28007476
No abstract available.
8.
Wilffert D, Donzelli R, Asselman A, Hermans J, Govorukhina N, Ten Hacken N, et al.
J Chromatogr B Analyt Technol Biomed Life Sci
. 2016 Jun;
1032:205-210.
PMID: 27250581
Soluble tumor necrosis factor-related apoptosis-inducing ligand (sTRAIL) induces apoptosis via the extrinsic death receptor pathway and may be a biomarker in the pathogenesis of a broad range of diseases. To...
9.
Hartman J, Boezen H, de Greef M, Ten Hacken N
Arch Phys Med Rehabil
. 2013 Jul;
94(12):2396-2402.e7.
PMID: 23872081
Objectives: To assess physical activity and sitting time in patients with chronic obstructive pulmonary disease (COPD) and to investigate which physical and psychosocial factors are associated with physical activity and...
10.
Martinez F, Helming L, Milde R, Varin A, Melgert B, Draijer C, et al.
Blood
. 2013 Jan;
121(9):e57-69.
PMID: 23293084
The molecular repertoire of macrophages in health and disease can provide novel biomarkers for diagnosis, prognosis, and treatment. Th2-IL-4–activated macrophages (M2) have been associated with important diseases in mice, yet...